Viewpoints on FDA: Enforcementis an invaluable resource for attorneys, manufacturers, consultants and other food and drug stakeholders, who want to know what FDA will be doing in the enforcement ar...read more
A tough question - but one that FDA, pharmaceutical manufacturers, physicians, patients and the courts now are urgently trying to answer. FDA has proposed rules that will make it easier for dying p...read more
Second in a series of discussion on should terminally ill patients get access
to unapproved drugs?
Full Transcript from FDLI’s Colloquium #2, From Abigail to Penelope: